Related Experiment Video
Updated: Jan 10, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.0K
Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group
Norlinah Mohamed Ibrahim1, Warongporn Phuenpathom2, Priya Jagota2
1Neurology Unit, Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Movement Disorders Clinical Practice
|November 27, 2025
Summary
Parkinson's disease care in Asia shows significant disparities. High-income countries offer better resources, while Central Asia lags, indicating a need for regional collaboration to improve Parkinson's disease management.
Area of Science:
- Neurology
- Public Health
- Health Services Research
Background:
- Parkinson's disease (PD) prevalence is rising in Asia.
- Comprehensive PD care infrastructure is urgently needed.
- Understanding regional and income-based disparities is crucial.
Purpose of the Study:
- To assess PD management resources and facilities across Asian regions and income levels.
- Focus on South East Asia, Middle East, Indian Subcontinent, East Asia, and Central Asia.
- Categorization by high-income countries (HIC), upper middle-income countries (UMIC), and lower middle-income countries (LMIC).
Main Methods:
- A survey-based questionnaire was distributed to neurologists and affiliate societies in 32 Asian countries.
- Data collected on availability and accessibility of healthcare professionals, medications, and facilities.
- Analysis focused on regional and income-based comparisons.
Main Results:
- Thirty countries participated, revealing significant disparities.
- HICs demonstrated superior availability and accessibility of healthcare professionals.
- Central Asia had the lowest accessibility; PD nurses were least available (33.3%) and accessible (6.7%).
- Levodopa and anticholinergics were universally available, accessible, and affordable.
- Device-aid therapies were more prevalent in East Asia.
- Allied health professional accessibility was poor (43%).
- Genetic testing was available in 60% of countries, primarily in HICs.
- Community engagement (70%) and telemedicine (70%) were utilized.
- Brain banks were scarce (24.1%), mainly in HICs.
Conclusions:
- This study is the first to detail regional and income-based infrastructure disparities for comprehensive PD care in Asia.
- Collaborations between HICs and middle-income countries (MICs) are recommended to address these inequalities.
- Targeted interventions are needed to improve PD care access and resources across Asia.
Related Concept Videos
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

